Marco Gerlinger

15.1k total citations
62 papers, 2.4k citations indexed

About

Marco Gerlinger is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marco Gerlinger has authored 62 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cancer Research, 28 papers in Oncology and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marco Gerlinger's work include Cancer Genomics and Diagnostics (29 papers), Genetic factors in colorectal cancer (14 papers) and Colorectal Cancer Treatments and Studies (13 papers). Marco Gerlinger is often cited by papers focused on Cancer Genomics and Diagnostics (29 papers), Genetic factors in colorectal cancer (14 papers) and Colorectal Cancer Treatments and Studies (13 papers). Marco Gerlinger collaborates with scholars based in United Kingdom, United States and Denmark. Marco Gerlinger's co-authors include Charles Swanton, Lajos Pusztai, Timothy A. Yap, P. Andrew Futreal, Louise J. Barber, Matthew N. Davies, Rebecca A. Burrell, Nicholas McGranahan, Naureen Starling and Kamil Lipiński and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Marco Gerlinger

58 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Gerlinger United Kingdom 22 1.2k 1.1k 955 647 290 62 2.4k
Patricia Galván Spain 20 997 0.9× 947 0.9× 1.4k 1.4× 671 1.0× 184 0.6× 69 2.4k
Leticia De Mattos‐Arruda Spain 26 1.4k 1.2× 947 0.9× 1.3k 1.4× 735 1.1× 425 1.5× 54 2.7k
Coya Tapia Switzerland 28 752 0.6× 838 0.8× 1.1k 1.2× 461 0.7× 253 0.9× 47 2.3k
Véronique Becette France 18 983 0.8× 889 0.8× 1.0k 1.1× 412 0.6× 313 1.1× 56 2.2k
Mónica Arnedos France 25 1.2k 1.0× 1.4k 1.3× 1.6k 1.7× 1.0k 1.6× 293 1.0× 90 3.1k
Matthias Christgen Germany 28 1.2k 1.1× 1.1k 1.0× 1.3k 1.3× 352 0.5× 323 1.1× 113 2.5k
Mohammed A. Aleskandarany United Kingdom 36 1.5k 1.3× 1.7k 1.5× 1.6k 1.7× 510 0.8× 382 1.3× 81 3.4k
Hege G. Russnes Norway 23 1.5k 1.3× 1.6k 1.5× 1.1k 1.2× 397 0.6× 310 1.1× 55 3.0k
Anne‐Vibeke Lænkholm Denmark 30 1.2k 1.0× 1.2k 1.1× 1.2k 1.3× 461 0.7× 276 1.0× 120 2.6k
Matthew T. Chang United States 14 862 0.7× 1.4k 1.3× 762 0.8× 571 0.9× 400 1.4× 18 2.3k

Countries citing papers authored by Marco Gerlinger

Since Specialization
Citations

This map shows the geographic impact of Marco Gerlinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Gerlinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Gerlinger more than expected).

Fields of papers citing papers by Marco Gerlinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Gerlinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Gerlinger. The network helps show where Marco Gerlinger may publish in the future.

Co-authorship network of co-authors of Marco Gerlinger

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Gerlinger. A scholar is included among the top collaborators of Marco Gerlinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Gerlinger. Marco Gerlinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Angelis, Vasileios, et al.. (2024). State of the art: Targeting microsatellite instability in gastrointestinal cancers. Critical Reviews in Oncology/Hematology. 199. 104387–104387. 1 indexed citations
3.
Harris, Valerie, Amy M. Boddy, Marco Gerlinger, et al.. (2024). Resistance Management for Cancer: Lessons from Farmers. Cancer Research. 84(22). 3715–3727. 4 indexed citations
4.
Gerlinger, Marco, et al.. (2023). Assessing the toxicity of bispecific antibodies. Nature Biomedical Engineering. 8(4). 339–340. 1 indexed citations
5.
Newey, Alice, Lu Yu, Louise J. Barber, et al.. (2023). Multifactorial Remodeling of the Cancer Immunopeptidome by IFNγ. Cancer Research Communications. 3(11). 2345–2357. 4 indexed citations
6.
Somarelli, Jason A., James DeGregori, Marco Gerlinger, et al.. (2022). Questions to guide cancer evolution as a framework for furthering progress in cancer research and sustainable patient outcomes. Medical Oncology. 39(9). 137–137. 6 indexed citations
7.
Woolston, Andrew, Louise J. Barber, B Griffiths, et al.. (2021). Mutational signatures impact the evolution of anti-EGFR antibody resistance in colorectal cancer. Nature Ecology & Evolution. 5(7). 1024–1032. 24 indexed citations
8.
Knebel, Franciele Hinterholz, Louise J. Barber, Alice Newey, et al.. (2020). Circulating Tumour DNA Sequencing Identifies a Genetic Resistance-Gap in Colorectal Cancers with Acquired Resistance to EGFR-Antibodies and Chemotherapy. Cancers. 12(12). 3736–3736. 4 indexed citations
9.
Loga, Katharina von, Andrew Woolston, Marco Punta, et al.. (2020). Extreme intratumour heterogeneity and driver evolution in mismatch repair deficient gastro-oesophageal cancer. Nature Communications. 11(1). 139–139. 43 indexed citations
10.
Loga, Katharina von, Andrew Woolston, B Griffiths, et al.. (2020). Computational Image Analysis of T-Cell Infiltrates in Resectable Gastric Cancer: Association with Survival and Molecular Subtypes. JNCI Journal of the National Cancer Institute. 113(1). 88–98. 16 indexed citations
11.
Newey, Alice, B Griffiths, Justine Michaux, et al.. (2019). Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment. Journal for ImmunoTherapy of Cancer. 7(1). 309–309. 91 indexed citations
12.
Khan, Khurum, Jayant K. Rane, David Cunningham, et al.. (2018). Efficacy and Cardiotoxic Safety Profile of Raltitrexed in Fluoropyrimidines-Pretreated or High-Risk Cardiac Patients With GI Malignancies: Large Single-Center Experience. Clinical Colorectal Cancer. 18(1). 64–71.e1. 11 indexed citations
13.
Goode, E., Francesco Sclafani, Joo Ern Ang, et al.. (2017). Treatment and Survival Outcome of BRAF-Mutated Metastatic Colorectal Cancer: A Retrospective Matched Case-Control Study. Clinical Colorectal Cancer. 17(1). e69–e76. 46 indexed citations
14.
Barber, Louise J., Matthew N. Davies, & Marco Gerlinger. (2014). Dissecting cancer evolution at the macro-heterogeneity and micro-heterogeneity scale. Current Opinion in Genetics & Development. 30. 1–6. 48 indexed citations
15.
Chau, Ian, Marco Gerlinger, & Martin Förster. (2013). Cardiac Toxicity of Raltitrexed in High-Risk Patients – Results of a Patient Audit. Annals of Oncology. 24. iv102–iv102.
16.
Gerlinger, Marco, Cláudio R. Santos, Bradley Spencer‐Dene, et al.. (2012). Genome‐wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target. The Journal of Pathology. 227(2). 146–156. 89 indexed citations
17.
Gerlinger, Marco & Laurence Albigès. (2011). The Personalized RNA Interference to Enhance the Delivery of Individualized Cytotoxic and Targeted Therapeutics (PREDICT) approach to biomarker discovery in renal cell carcinoma.. Journal of Clinical Oncology. 29(15_suppl). TPS179–TPS179. 2 indexed citations
18.
Gerlinger, Marco & Charles Swanton. (2010). How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine. British Journal of Cancer. 103(8). 1139–1143. 325 indexed citations
19.
Gerlinger, Marco, Peter Wilson, Thomas Powles, & Jonathan Shamash. (2010). Elevated LDH predicts poor outcome of recurrent germ cell tumours treated with dose dense chemotherapy. European Journal of Cancer. 46(16). 2913–2918. 15 indexed citations
20.
Walton, Senta M., Marco Gerlinger, Olga de la Rosa, et al.. (2006). Spontaneous CD8 T Cell Responses against the Melanocyte Differentiation Antigen RAB38/NY-MEL-1 in Melanoma Patients. The Journal of Immunology. 177(11). 8212–8218. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patricia Galván Breakdown of academic impact, for papers by Leticia De Mattos‐Arruda Breakdown of academic impact, for papers by Coya Tapia Breakdown of academic impact, for papers by Véronique Becette Breakdown of academic impact, for papers by Mónica Arnedos Breakdown of academic impact, for papers by Matthias Christgen Breakdown of academic impact, for papers by Mohammed A. Aleskandarany Breakdown of academic impact, for papers by Hege G. Russnes Breakdown of academic impact, for papers by Anne‐Vibeke Lænkholm Breakdown of academic impact, for papers by Matthew T. Chang
Rankless by CCL
2026